Four Renowned Medical Doctors Join Forces to Launch MDbio, Patient-Tested Plant-Based Medicines Targeting Common Ailments
Retrieved on:
Tuesday, March 22, 2022
CBC, GABA, DPM, Quercetin, Foot, Doctor of Medicine, Food, Pain, Health, Industry, Vitamin, Gastroenterology, CBG, CBN, Zinc, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, GLOBE, Physician, Solution, Hepatology, Anxiety, Ankle, American Academy of Otolaryngology–Head and Neck Surgery, Organic acid, Doctor, Patient, Disease, FACS, Pharmaceutical industry, Dietary supplement, MD, CBD
Los Angeles, March 22, 2022 (GLOBE NEWSWIRE) -- MDbio , The Doctors Brand committed to providing therapeutic plant-based medicines, today announced its official launch.
Key Points:
- Los Angeles, March 22, 2022 (GLOBE NEWSWIRE) -- MDbio , The Doctors Brand committed to providing therapeutic plant-based medicines, today announced its official launch.
- Founded by four renowned medical doctors inSouthern California, with over 80 combined years of patient care, MDbio combines the best of modern science with holistic remedies through medical-grade, patient-tested Full Spectrum Hemp + high-potency botanical products.
- MDbio originates with four Board-Certified Medical Doctors whose career-long mission has been to maximize positive patient outcomes and minimize harm.
- All MDBio products are now available on mdbiowellness.com and can be purchased in 10, 30 or 60 count quantities for$14.95$74.95.